Frontlight ResearchEarly access
Trial site
NEXT Oncology - Dallas
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer4 trials
- Lung cancer3 trials
- Melanoma3 trials
- Pancreatic cancer3 trials
- Bladder cancer2 trials
- Ovarian cancer2 trials
- Triple-negative breast cancer2 trials
- Cervical cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 14 trials
- Phase 1/22 trials
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Auricula Biosciences Inc.1 trial
- Hefei TG ImmunoPharma Co., Ltd.1 trial
- Innate Pharma1 trial
- Nested Therapeutics, Inc1 trial
- SystImmune Inc.1 trial
- and 1 more
Running trials
Recruiting
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer3 recruiting
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Bladder cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026